High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
about
How cell death shapes cancerSystematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskGenetic polymorphisms of Bcl-2 promoter in cancer susceptibility and prognosis: a meta-analysis.Combination therapy in combating cancer.MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2.Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic reviewBcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.A method for biomarker directed survival prediction in advanced non-small-cell lung cancer patients treated with Carboplatin-based therapy.Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis.Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.Lung Cancer Staging and Prognosis.Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.Gelidiella acerosa inhibits lung cancer proliferation.Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.
P2860
Q27021441-9C6EE1A3-C74B-45AE-BB67-1320493B7C50Q28391725-F28BCDDD-F1E9-4F6F-B322-30051F57059AQ33648842-276BFD48-B094-4230-8A71-730CC297B1CCQ33914234-A6EDF863-011D-492E-8E2B-0B729F957373Q35098110-7C768144-DB1A-4757-A909-811F63377EF3Q35851986-15F156D6-B126-4F03-B06F-1FD668028EAFQ36567569-CB7AE35F-482C-4917-AA5C-D8478805207DQ37362905-89BF4CFF-5F63-4857-B965-1B8E1DDD063CQ37384203-91BEBC32-D0E2-487A-815B-EFBFF8D8FDAFQ37741375-7C8CC754-D1FF-486E-AC58-FB9AE3806E86Q38327212-B1901395-6ECE-4B56-86FE-66320A742122Q38682214-17B731B5-5E76-4D0E-ACB3-A31050E07E75Q38830349-057F3137-0A9E-4990-8507-2AF2A9218A3EQ50197145-1E8C67D2-A790-4F13-AEF5-9A939944DC8BQ54120349-04A70A15-76CE-4A95-8E27-DF5E6B3F86B4Q55451018-7F5A7BF5-53D5-4385-BA36-4ABB3516F595
P2860
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High expression of BCL-2 predi ...... s with non squamous histology.
@ast
High expression of BCL-2 predi ...... s with non squamous histology.
@en
High expression of BCL-2 predi ...... s with non squamous histology.
@nl
type
label
High expression of BCL-2 predi ...... s with non squamous histology.
@ast
High expression of BCL-2 predi ...... s with non squamous histology.
@en
High expression of BCL-2 predi ...... s with non squamous histology.
@nl
prefLabel
High expression of BCL-2 predi ...... s with non squamous histology.
@ast
High expression of BCL-2 predi ...... s with non squamous histology.
@en
High expression of BCL-2 predi ...... s with non squamous histology.
@nl
P2093
P2860
P50
P356
P1433
P1476
High expression of BCL-2 predi ...... s with non squamous histology.
@en
P2093
Arun Gopinath
Camil Liceaga
Daniel Boffa
David L Rimm
Dimitrios Dougenis
Frank Detterbeck
Konstantina Frangia
Konstantinos N Syrigos
Lynn Tanoue
Nikolaos Panagopoulos
P2860
P2888
P356
10.1186/1471-2407-10-186
P407
P577
2010-05-09T00:00:00Z
P5875
P6179
1025931846